← FDA Drug Approvals (Drugs@FDA)

AMIKACIN SULFATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: QILU · Approved 2024-03-19

Drug application

FDA Application #

ANDA218146

Application type

Abbreviated New Drug Application (Generic)

Brand name

AMIKACIN SULFATE

Generic name

AMIKACIN SULFATE

Active ingredients

AMIKACIN SULFATE

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Prescription

Sponsor

QILU

Manufacturer

Mullan Pharmaceutical Inc.

First approval

2024-03-19

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown